Drug: THALOMID Injury: Plasma cell myeloma Quarter: 2016Q3
Total Records: 30 Number of Pages: 2
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
116266634 | THALOMID | Plasma cell myeloma | CELGENE | 55.34 YR | M | 77 KG | 20160912 | US |
122577302 | THALOMID | Plasma cell myeloma | CELGENE | 66.46 YR | M | 50 KG | 20160804 | US |
122789404 | THALOMID | Plasma cell myeloma | CELGENE | 0.00 | F | 0 | 20160715 | US |
123189443 | THALOMID | Plasma cell myeloma | CELGENE | 86.25 YR | M | 0 | 20160815 | US |
124690582 | THALOMID | Plasma cell myeloma | CELGENE | 65.25 YR | M | 0 | 20160801 | US |
124736272 | THALOMID | Plasma cell myeloma | CELGENE | 54.91 YR | M | 0 | 20160902 | US |
124757452 | THALOMID | Plasma cell myeloma | CELGENE | 76.14 YR | M | 0 | 20160725 | US |
125309641 | THALOMID | Plasma cell myeloma | CELGENE | 79.52 YR | M | 0 | 20160706 | US |
125382621 | THALOMID | Plasma cell myeloma | CELGENE | 0.00 | M | 81 KG | 20160707 | US |
125493022 | THALOMID | Plasma cell myeloma | CELGENE | 0.00 | F | 0 | 20160719 | US |
125656021 | THALOMID | Plasma cell myeloma | CELGENE | 55.63 YR | 0 | 20160718 | US | |
126016631 | THALOMID | Plasma cell myeloma | CELGENE | 0.00 | M | 0 | 20160728 | US |
126033641 | THALOMID | Plasma cell myeloma | CELGENE | 65.00 YR | M | 77 KG | 20160728 | US |
126074571 | THALOMID | Plasma cell myeloma | CELGENE | 59.00 YR | M | 0 | 20160729 | US |
126082772 | THALOMID | Plasma cell myeloma | CELGENE | 51.00 YR | M | 0 | 20160729 | US |
126099482 | THALOMID | Plasma cell myeloma | CELGENE | 58.00 YR | F | 0 | 20160801 | US |
126099711 | THALOMID | Plasma cell myeloma | CELGENE | 55.00 YR | M | 0 | 20160801 | US |
126114762 | THALOMID | Plasma cell myeloma | CELGENE | 75.66 YR | M | 0 | 20160811 | US |
126165303 | THALOMID | Plasma cell myeloma | CELGENE | 0.00 | M | 85 KG | 20160816 | US |
126235111 | THALOMID | Plasma cell myeloma | CELGENE | 60.46 YR | F | 64 KG | 20160804 | US |
Total Records: 30 Number of Pages: 2